Table 3:
Year, Location |
Donor
risk factors and testing |
Organ donated |
Onset of
symptoms post-transplant |
Recipient serum testing |
Recipient CSF testing | Treatment | Outcome |
---|---|---|---|---|---|---|---|
2011 US45,96 |
Increased WNV activity in donor region Serum IgM and IgG pos, serum NAT neg, LN PCR pos, spleen PCR pos |
Kidney | Day 10 | NAT pos |
NAT pos, IgM neg | IVIG, IFN α2b | Remained in coma, developed status epilepticus, died on day 23 |
Kidney | Day 17 | NAT pos, IgM pos | NAT pos, IgM neg | IVIG, IFN α2b, FFP containing WNV IgG |
Resolved, no neurologic deficits | ||
Bilateral lungs | Day 20 | NAT pos | NAT pos, IgM pos | IVIG, IFN α2b | Complete flaccid paralysis, multiple seizures, died on day 38 | ||
Liver | Day 18 | NAT neg, IgM neg, IgG pos | NAT pos, IgM neg | Oral ribavirin, IVIG | Resolved, asymptomatic | ||
2011 Italy97,98 |
Donor mosquito
bite NAT neg, IgM pos, IgG pos |
Kidney | Day 10 | NAT pos, IgM pos, IgG pos | NAT pos, IgM pos, IgG pos |
WNV IgG-pos FFP | Neuroinvasive disease, remained in coma |
Kidney | Day 10 | NAT pos, IgM pos, IgG pos | NAT pos, IgM pos, IgG pos |
None | Neuroinvasive disease | ||
Liver | Asymptomatic | NAT neg, IgM pos, IgG pos | None | None | Asymptomatic infection | ||
Single Lung | Asymptomatic | NAT pos, IgM pos, IgG pos | None | None | Asymptomatic infection | ||
Heart | Asymptomatic | NAT neg, IgM neg, IgG neg | None | None | Not infected | ||
2010 California89 |
Donor mosquito
bite Serum NAT pos, IgM neg, IgG pos |
Kidney | Day 8 | IgM pos, IgG pos | NAT neg, IgM pos | Supportive care | Neuroinvasive disease, died |
Kidney | Asymptomatic | NAT pos, IgM pos, IgG pos | Not obtained | None | Asymptomatic | ||
Liver | Asymptomatic | NAT neg, IgM neg, IgG pos | Not obtained | None | Asymptomatic | ||
2009 Italy45,57 |
Donor mosquito bite Serum NAT pos |
Liver | Asymptomatic | NAT pos, IgM pos | Not obtained |
Prophylaxis with WNV IgG+ FFP, Omr-IgG-am | Asymptomatic |
2009 (Unpublished CDC data)89 |
Donor mosquito
bite NAT pos, IgM pos, IgG equivocal |
Kidney | Not described | Not described | Not described | Not described | Neuroinvasive disease, resolved |
Kidney | Asymptomatic | Not described | Not described | Not described | Asymptomatic | ||
Liver | Asymptomatic | Not described | Not described | Not described | Asymptomatic | ||
2009 California48 |
Possible donor
mosquito bite Serum NAT pos, IgM neg |
Liver | Day 15 | NAT neg, IgM pos, IgG neg 3 weeks later: IgG pos |
IgM pos | IVIG | Neuroinvasive disease, resolved |
2008 Louisiana44,89 |
Donor blood transfusion Serum NAT neg, IgM neg, IgG neg; one blood donor for organ donor IgM pos |
Heart | Day 8 | IgM pos | IgM pos | Supportive care |
Neuroinvasive disease, survived |
2005 New York, Pennsylvania92 |
Probable donor mosquito
bite Serum NAT neg, IgM pos, IgG pos |
Liver | Day 13 | IgM pos | NAT pos, IgM pos |
Omr-IgG-am |
Neuroinvasive disease, coma |
Lung | Day 17 | Day 19: IgM neg Day 23: IgM pos, IgG pos |
Day 24: NAT neg, IgM neg Day 27: IgM pos, IgG pos |
Omr-IgG-am | Neuroinvasive disease, coma | ||
Kidney | Asymptomatic | NAT pos, IgM neg, IgG pos | Not obtained |
Prophylactic Omr-IgG-am |
Asymptomatic | ||
Kidney | Asymptomatic | IgM neg, IgG neg, NAT neg |
Not obtained |
Prophylactic Omr-IgG-am |
Not infected | ||
2002 Georgia, Florida33,99,100 |
Donor blood
transfusion Serum NAT pos |
Kidney | Day 13 | Day 22: IgM equivocal,IgG equivocal Day 42: IgM pos |
IgM pos | None | Neuroinvasive disease, survived |
Kidney | Day 17 | IgM neg, IgG neg | IgM neg, IgG neg | None | Neuroinvasive disease, died | ||
Heart | Day 8 | NAT pos, IgM pos | IgM pos | None | Neuroinvasive disease, improved | ||
Liver | Day 7 | IgM pos | Not obtained | None | Resolved |
Abbreviations: d, days; FFP, fresh frozen plasma; IFN, interferon; IVIG, Intravenous immunoglobulin; LN, lymph node; mpNAT, minipool nucleic acid-amplification test; Neg, negative; PCR, polymerase chain reaction; Pos, positive; QOD, every other day; US, United States